Please login to the form below
depression
This page shows the latest depression news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca wins NICE backing for asthma injection
hold them back from doing many basic daily tasks, lead to psychological problems including anxiety and depression, and leave them in constant fear of a potentially lethal asthma attack.
Latest news
-
Janssen submits esketamine in Europe for treatment resistant depression
Janssen has filed its new nasal spray-administered treatment for treatment resistant depression with the European Medicines Agency (EMA). ... Esketamine is a glutamate receptor modulator, for treatment-resistant depression (TRD) in adults with Major
-
New data keeps AbbVie’s star pipeline therapies on track
There were also significant improvements for AbbVie’s drug over Humira on quality of life measures and over Stelara on anxiety and depression, and risankizumab did better than both comparator drugs
-
Daily Brief: another departure at Gilead, veteran researcher to head up Karuna
Steven Paul, a veteran researcher who played a key role in developing Lilly’s antipsychotic and depression blockbuster drugs such as Zyprexa and Cymbalta is to head up efforts to find
-
Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
researchers’ time). Many of the proposed projects address brain disorders, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, major depression, and immune-mediated diseases such as Crohn’s
-
Sage surges after depression drug gets rapid path to approval
The FDA has given its blessing to an expedited development route for Sage Therapeutics’ depression pill SAGE-217, upgrading its ongoing study to a pivotal trial. ... SAGE-217 is being tested in post-partum depression (PPD) that affects mother after
More from news
Approximately 20 fully matching, plus 285 partially matching documents found.
Latest Intelligence
-
AstraZeneca’s oncology renaissance
This saw phase 3 flops of drugs for stroke, prostate cancer and depression – failures that dented confidence in the firm as patent expiries for its blockbusters Crestor and Nexium loomed on
-
Health on instalment
But the Depression annihilated all that refinance money overnight, leaving millions in the lurch. ... to Wall Street and institutional investors - in a strategy not unlike how mortgages were lengthened during the Great Depression.
-
Speech therapy
The first of these studies looked at ‘Woebot’, a Facebook Messenger bot delivering text-based cognitive behavioural therapy, which successfully reduced self-reported symptoms of depression in its users.
-
Finding the patient voice
With chronic conditions (15%) or fighting mental illness like depression (12%), most of them hope to find a permanent solution by joining a trial.
-
Here’s to all the bright sparks
Or marketing revolutionary total knee replacements to defining new cures for depression… The future of healthcare is a wonderful place.
More from intelligence
Approximately 0 fully matching, plus 24 partially matching documents found.
Latest appointments
-
Clark Health Communications expands team
director in a role that will see her lead teams responsible for driving the delivery of CHC’s gastroenterology, women’s health, depression and anticoagulants business.
-
Dr Niall Murphy and Pierre Schwich join Pharnext
Prior to this, Dr Murphy served as a unit leader for a team of scientists collaborating on research in the areas of addition biology, Alzheimer's disease, anxiety, depression and neurotoxicity
-
Turing names Eliseo Salinas as head of R&D
Salinas has played a leading role in numerous programmes for a range of diseases and disorders, with specific focus on central nervous systems (CNS) condition such as depression and anxiety, schizophrenia,
-
Lundbeck promotes Andreas Eggert and Klaus Abel to senior commercial roles
vortioxetine for major depression and Selincro (nalmefene) for alcohol dependence. ... including a once-monthly aripiprazole formulation for the treatment of schizophrenia and brexpiprazole (OPC-34712) for the treatment of schizophrenia and major
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Neurostimulation Market Set to Grow Exponentially During the Forecast, 2025
Neurostimulation is used for the treatment of various debilitating conditions such as gastroparesis, incontinence, Parkinson’s disease, epilepsy, depression and essential tremors. ... Deep brain stimulators are currently approved for the treatment of
-
Aromatherapy Market : Quantitative Market Analysis, Current and Future Trends, 2016-2026
channel. Medical centers offering therapeutic treatments have initiated promotions for the use of aromatherapy in the treatment of generic ailments such as headaches, anxiety and depression.
-
World Diabetes Day: Interaction and impact of diabetes on mental health
Depression exists in one in five adult diabetics (14), and diabetes distress affects one third of adult diabetics [15]. ... Diabetes distress is distinct from depression as it is caused by the emotional burden of managing diabetes [15].
-
Healthcircle
DermatologyAnalgesia. Anti-psychotics. Cancer Supportive-care. OTC &Consumers. Pain. Acne. Arthritis. Dandruff. Depression.
-
How health behaviours and clinical outcomes are related
Patients suffering from post-traumatic stress disorder, schizophrenia, bipolar disorder and depression also have more positive outcomes with higher patient activation levels. .
More from PMHub
Approximately 3 fully matching, plus 23 partially matching documents found.
Featured jobs
-
Senior Account Manager
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
-
Account Manager / Account Director
-
Competative
-
Senior Medical Writer
-
Salary TBC
-
Associate Director
-
£75, 000-90, 000
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Global Business Development Director – Health Education
-
excellent commission
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
-
Account Director
-
Competitive Salary Offered
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Business Director
-
Competitive Salary Offered
-
Account Director, Medical Education
-
Salary TBC
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- FDA expecting boom in cell and gene therapies
- Moving annual total (MAT)
- AZ’s Sean Bohen to exit after business overhaul; report
- FDA moves into crisis mode as shutdown drags on
- Lucid Group prepare for a transformative year with the appointment of a new Director of Corporate Development
PMHub
Hive
We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...
Latest intelligence
- NHS regional footprints
- What to expect from 2019...
- Not another weight-loss ad
- Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
- China’s clinical trial shake-up
- As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Quick links
Infographics
